The MRC Clinical Trials Unit (CTU) is a centre of excellence for clinical trials, meta-analyses and epidemiological studies.
We are committed to strengthening and expanding the evidence-base for healthcare nationally and internationally.
The MRC CTU is a UKCRC registered trials unit.
Read more about the Unit
MDP301 Phase III trial of PRO 2000 vaginal microbicide gel- results announced
The phase III MDP301 trial evaluated the vaginal microbicide gel PRO2000 against a placebo gel for safety and effectiveness in reducing the risk of HIV transmission. The study found no evidence that the vaginal microbicide, PRO 2000, reduces the risk of HIV infection in women.
Read more
Thousands more could be treated for HIV in Africa if expensive routine lab tests are dropped
A third more people could be successfully treated for HIV in Africa if expensive lab tests, routinely used for monitoring side effects, are abandoned, according to the ‘Development of Anti-Retroviral Therapy in Africa (DART)’ clinical trial funded by the Medical Research Council.
MRC Clinical Trials Unit launched the Help Make History initiative on the July 19th 2010 Help Make History is a website and database for healthy volunteers to register and join a network of people wishing to take part in future HIV vaccine clinical trials.
Read full report
OV05 Trial Results presented at ASCO May 2009
More news and press releases
Our Research Areas
